Pricing

Oncternal Therapeutics Inc (ONCT)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
James B. Breitmeyer
Employees:
30
12230 EL CAMINO REAL, SUITE 230, SAN DIEGO, CA, 92130
(858) 434-1113
Stock Split History
DateRatio
2016-12-06 1:10
2019-06-10 1:7
2024-01-08 1:20
Oncternal Therapeutics, Inc. focuses on the development of oncology therapies for cancers with critical unmet medical needs. Company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1)
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available